Immunofluorescence kit for detecting CEA expression of peripheral blood circulating tumor cells of gastric cancer patient and detection method

A technology for peripheral blood circulation and tumor cells, which is applied in biological testing, separation methods, chemical instruments and methods, etc., can solve problems such as false negatives, false positives in detection methods, and the inability of tissue samples to evaluate the real-time dynamic status of CEA in patients, so as to reduce the number of cells Loss, good stability, avoid the effect of edge effect

Inactive Publication Date: 2020-09-11
山东凯歌智能机器有限公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] Aiming at the shortcomings in the prior art that the detection of patients with advanced tumors or recurrent gastric cancer cannot be obtained by real-time or repeated puncture tissue samples, and thus the real-time dynamic state of the patient's CEA cannot be evaluated, and the existing detection methods are prone to false positives and false negatives, the present invent

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Immunofluorescence kit for detecting CEA expression of peripheral blood circulating tumor cells of gastric cancer patient and detection method
  • Immunofluorescence kit for detecting CEA expression of peripheral blood circulating tumor cells of gastric cancer patient and detection method
  • Immunofluorescence kit for detecting CEA expression of peripheral blood circulating tumor cells of gastric cancer patient and detection method

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0049] Example 1

[0050] 1. Use a membrane filtration device to separate and obtain CTC in the peripheral blood of patients with advanced or recurrent gastric cancer who cannot obtain tissue samples to determine whether CTC exists:

[0051] Collect 5ml of fasting blood for 8-12 hours from the median cubital vein, dilute the peripheral blood with 45ml of diluent, and then add 3ml of 4% paraformaldehyde to fix the diluted blood sample for 10 minutes;

[0052] In a fixed interval, assemble the membrane filtration device: as attached figure 1 , figure 2 , image 3 As shown, the filtering device is composed of a filter 3, a filter membrane 7, a blood sample container 2, a waste liquid tank 5, and an iron stand 1;

[0053] Wet the filter 3 with 10ml PBS, and then add the fixed peripheral blood sample to the blood sample container 2 of the membrane filtration device to make it filter naturally by gravity, and the CTC is trapped on the filter membrane 7;

[0054] The diameter of tumor cells i...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Diameteraaaaaaaaaa
Diameteraaaaaaaaaa
Login to view more

Abstract

The invention discloses an immunofluorescence kit for detecting CEA expression of peripheral blood circulating tumor cells of a gastric cancer patient and a detection method. Circulating tumor cells (CTC) in peripheral blood of an advanced gastric cancer patient are separated by using a membrane filtration device, and the CEA expression condition on CTC is further detected by using an immunofluorescence technology. According to the detection method provided by the invention, the CEA expression condition of a patient suffering from advanced or recurrent gastric cancer can be detected without obtaining a tissue specimen through needle biopsy. According to the method provided by the invention, the circulating tumor cells are well separated, the interference of blood cells can be avoided, a false positive result caused by an edge effect possibly generated in a dyeing process can be avoided, the stability is good, the loss of the cells is reduced, and the detection accuracy is improved. Themarker CEA shows good specificity and sensitivity in use, and the application of the marker CEA in gastric cancer is improved.

Description

technical field [0001] The invention provides an immunofluorescent kit and detection method for detecting the expression of CEA in peripheral blood circulating tumor cells of patients with gastric cancer and belongs to the technical field of molecular biology. Background technique [0002] Gastric cancer (GC) is a highly fatal malignant tumor with the fourth highest incidence in the world (950,000 new cases per year), and the third highest among cancer-related deaths in 2012. Although the diagnosis and treatment methods of gastric cancer have improved in recent years, the 5-year survival rate of gastric cancer patients is less than 30%, and about 50% of gastric cancer patients suffer from tumor recurrence or metastasis after curative resection. Tumor recurrence and metastasis are the main causes of death in gastric cancer patients. [0003] Circulating tumor cells (CTCs) are tumor cells shed from solid tumors and enter the peripheral blood circulation. Since their discovery...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): G01N33/58G01N33/574G01N33/569B01D29/05
CPCB01D29/05G01N33/56966G01N33/57446G01N33/57473G01N33/582
Inventor 李琛琛洪瑛侯景阳李文涛
Owner 山东凯歌智能机器有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products